Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy
作者单位:German Cancer Consortium (DKTK) Partner Site Essen/Düsseldorf[1]German Cancer Consortium (DKTK) Partner Site Essen/DüsseldorfUniversity of Münster Department of[2]German Cancer Consortium (DKTK) Partner Site Essen/DüsseldorfUniversity of Duisburg-Essen[3]